Human Oncogene EWS::FLI1 Functions as a Pioneer Factor in Saccharomyces cerevisiae.

This study demonstrates that while the human oncoprotein EWS::FLI1 can function as a pioneer factor to convert silent GGAASat sequences into active enhancers in *Saccharomyces cerevisiae* despite the absence of key animal-specific cofactors, its ability to drive extensive transcriptome reprogramming relies on evolutionarily recent animal-specific pathways.

The Gist

The Big Picture: A Human Villain in a Yeast World

Imagine Ewing Sarcoma as a very aggressive, human-only criminal gang. The "boss" of this gang is a fusion protein called EWS::FLI1. This boss is a chimera: it has the "muscle" of one protein (EWS) and the "eyes" of another (FLI1).

In human cells, this boss is terrifying. It scans the DNA, finds specific spots (like a secret code made of repeating letters GGAA), and forces the cell to rewrite its entire instruction manual. It turns normal cells into cancer cells by hijacking the cell's machinery.

The scientists in this paper asked a fascinating question: Does this boss need a whole army of human-specific helpers to do its evil work, or is it powerful enough to do it alone in a much simpler world?

To find out, they dropped this human cancer boss into yeast (Saccharomyces cerevisiae). Yeast is like a "stripped-down" version of a cell. It's a simple, single-celled organism that lacks many of the complex tools and helpers that human cells have. It's like testing a high-tech fighter jet in a bicycle shop.

The Experiment: Dropping the Boss into the Bike Shop

The researchers put the human EWS::FLI1 protein into yeast cells and watched what happened. They looked at three main things:

1. Who did the boss shake hands with? (The Interactome)
2. Did the boss rewrite the instruction manual? (The Transcriptome)
3. Could the boss unlock a locked door? (The GGAA Microsatellites)

1. The Handshake: Who is the Boss Friends With?

In human cells, EWS::FLI1 is a social butterfly. It shakes hands with dozens of complex protein teams (like the BAF complex, spliceosomes, and others) to get its job done.

In Yeast:
When the human boss entered the yeast "bike shop," it found very few friends.

• The Good News: It still found the "core machinery," like the RNA Polymerase II (the cell's photocopier) and the FACT complex (a helper that moves the photocopier along the DNA). This is like the boss finding a basic screwdriver and a hammer.
• The Bad News: The fancy, human-specific teams were missing. The yeast didn't have the "BAF team" or the "spliceosome team."
• The Surprise: Instead of the human teams, the boss surprisingly started hanging out with the SAGA complex (a yeast protein team that helps turn genes on). It seems the boss is adaptable; when it can't find its usual human friends, it grabs whatever yeast tools are available to get the job done.

2. The Instruction Manual: Did the Chaos Spread?

In human cells, EWS::FLI1 causes massive chaos. It rewrites thousands of instructions, turning the cell into a cancer factory.

In Yeast:
The result was surprisingly calm.

• Even after the boss was present for several hours, the yeast cells only changed a tiny number of instructions (less than 100 genes).
• In human cells, this number would be in the thousands.
• The Analogy: Imagine dropping a master chef into a small kitchen. In a big restaurant (human cell), he might try to cook a 50-course meal and burn everything down. In the small kitchen (yeast), he tries to cook, but there are only a few ingredients available, so he only manages to change a couple of recipes. The kitchen doesn't explode; it just runs a little differently.

Why? The scientists realized that the "massive chaos" in humans requires specific animal-only helpers (like ETS transcription factors) that yeast simply doesn't have. Without these helpers, the boss can't cause a total meltdown.

3. The Locked Door: Can the Boss Still Open It?

Here is the most amazing part of the study.

In humans, the boss targets specific DNA sequences called GGAA microsatellites. These are like "secret locks" on the DNA. In normal cells, these locks are jammed shut (silenced). The boss uses its power to pick the lock, turn the "off" switch to "on," and create a new "enhancer" (a super-starter for genes). This is how it drives cancer.

The Yeast Test:
Yeast doesn't naturally have these GGAA locks. So, the scientists artificially installed a GGAA lock right in front of a yeast gene that glows green (GFP).

• Without the Boss: The lock stays jammed. The gene is silent. The yeast is dark.
• With the Boss: The human EWS::FLI1 arrived, recognized the GGAA lock, and successfully picked it! The gene turned on, and the yeast started glowing bright green.

The Takeaway: Even though the yeast lacked the human "BAF team" and the human "p300 helper" (which are usually needed to pick this lock), the boss still managed to do it. It seems the boss is so powerful that it can recruit whatever yeast tools it finds (like the SAGA complex) to act as a substitute for the missing human tools.

The Grand Conclusion

This paper tells us two very important stories about the EWS::FLI1 cancer boss:

1. The Core Power is Ancient: The ability to find the GGAA lock and turn it into an "on" switch is a fundamental, ancient power. It doesn't need the fancy, human-specific tools to do this specific trick. It can do it even in a simple yeast cell.
2. The "Chaos" is Human-Specific: The massive destruction and rewriting of the cell's entire instruction manual (which leads to aggressive cancer) does require the complex, human-specific helpers. Without them, the boss is just a troublemaker, not a world-ender.

In simple terms: The EWS::FLI1 protein is a master key. It can open a specific door (the GGAA lock) almost anywhere, even in a simple shed (yeast). But to burn down the whole house (cause full-blown cancer), it needs a whole crew of human arsonists that only exist in complex animals.

This discovery helps scientists understand exactly which parts of the cancer process are essential and which parts are just "extra baggage" that might be targeted with new drugs.

Technical Summary

1. Problem Statement and Rationale

Ewing sarcoma (EwS) is an aggressive human tumor driven by the EWS::FLI1 fusion oncoprotein. This protein functions by binding to GGAA-microsatellites (GGAAμSats) and recruiting chromatin remodeling complexes (such as BAF/SWI-SNF) and co-activators (like CBP/p300) to convert heterochromatic regions into active enhancers ("neo-enhancers"), leading to massive transcriptome reprogramming.

A critical unanswered question is whether the neomorphic (new) functions of EWS::FLI1 depend on evolutionarily recent cofactors specific to metazoans (e.g., specific ETS transcription factors, Polycomb group proteins, NuRD complex, or specific BAF subunits) or if its core ability to drive gene expression is an ancient, conserved property. Previous studies in Drosophila showed EWS::FLI1 could induce transcriptional changes despite the lack of native GGAAμSats, but Drosophila still retains many metazoan-specific cofactors.

To address this, the authors utilized Saccharomyces cerevisiae (budding yeast) as a "minimal system." Yeast lacks:

• Native GGAAμSats.
• Endogenous ETS transcription factors.
• Polycomb group (PcG) proteins and NuRD complexes.
• Direct orthologs of mammalian BAF complexes (though it has SWI/SNF, they differ significantly in subunit composition and structure).
• Direct homologs of CBP/p300.

The study aims to determine if EWS::FLI1 can function in this stripped-down environment and what molecular machinery it recruits in the absence of human-specific cofactors.

2. Methodology

The researchers expressed human EWS::FLI1 in the yeast strain S. cerevisiae (DVS050) using a galactose-inducible promoter ($P_{GAL1}$). They employed a multi-omics approach:

• Interactome Mapping (Co-IP/MS): Immunoprecipitation of EWS::FLI1 followed by Mass Spectrometry to identify yeast proteins interacting with the fusion protein.
• Transcriptomics (RNA-Seq): Analysis of global gene expression changes at 3 and 6 hours post-induction, comparing wild-type EWS::FLI1, a DNA-binding mutant (EWS::FLI1$^{RRLL}$), and empty vector controls.
• Chromatin Binding (ChIP-Seq): Genome-wide mapping of EWS::FLI1 binding sites and RNA Polymerase II (RNA Pol II) redistribution.
• Reporter Assays: Construction of yeast strains integrating synthetic promoters containing varying lengths of (GGAA)$_n$ repeats (10x, 20x, 40x) upstream of a CYC1p-driven eGFP reporter to test:
  1. Whether GGAA repeats silence transcription in yeast.
  2. Whether EWS::FLI1 can reactivate (convert) these silenced regions into active enhancers.
• Controls: Use of DNA-binding mutants (EWS::FLI1$^{RRLL}$) and prion-domain mutants (EWS::FLI1$^{YS37}$) to dissect the mechanisms of binding and condensate formation.

3. Key Results

A. The Yeast Interactome is Distinct but Functional

• Limited Interactome: EWS::FLI1 interacted with only 54 yeast proteins, significantly fewer than in human or Drosophila cells.
• Core Machinery Retained: It successfully recruited RNA Polymerase II and the FACT complex (histone chaperone), which are essential for transcription.
• Novel Recruitment (SAGA): Unlike in humans or flies, the yeast interactome showed a striking enrichment for the SAGA complex (10 subunits identified). SAGA is a histone acetyltransferase (HAT) complex in yeast, functionally analogous to the human p300/CBP and BAF complexes in terms of chromatin remodeling, despite lacking sequence homology.
• Missing Components: The interactome lacked the spliceosome and SWI/SNF (yeast BAF homolog) complexes, suggesting EWS::FLI1 does not rely on these specific yeast counterparts for its core activity.

B. Minimal Transcriptomic Dysregulation

• Low Impact: Expression of EWS::FLI1 in yeast caused minimal transcriptional changes (73 upregulated, 13 downregulated genes at 6 hours). This is an order of magnitude lower than the hundreds of genes dysregulated in human or Drosophila cells.
• Cause of Dysregulation: The few changes observed were largely associated with stress responses and metabolic shifts, likely secondary to the toxicity of the oncogene rather than direct transcriptional reprogramming.
• Conclusion: The massive transcriptome reprogramming seen in EwS is dependent on animal-specific cofactors (e.g., specific ETS factors, BAF subunits) absent in yeast.

C. DNA Binding and RNA Pol II Relocalization

• Binding Specificity: EWS::FLI1 bound to 834 genomic sites in yeast.
• Motif Preference: Binding was strongly enriched for putative ETS consensus sequences (CCGGAAAT) and (CA) dinucleotide repeats.
• RNA Pol II Redistribution: EWS::FLI1 binding caused a massive relocalization of RNA Pol II. 95% of newly acquired RNA Pol II sites overlapped with EWS::FLI1 binding sites.
• Decoupling: Despite this widespread relocalization of the transcription machinery, most of these sites did not result in gene activation. This suggests that while EWS::FLI1 can recruit Pol II, the full activation of transcription requires additional metazoan-specific factors.

D. Pioneer Activity on GGAA Microsatellites

• Silencing Effect: Introducing (GGAA) repeats upstream of a constitutive promoter in yeast caused transcriptional silencing (heterochromatin formation), with longer repeats (20x, 40x) causing stronger repression.
• Rescue by EWS::FLI1: Crucially, expression of wild-type EWS::FLI1 reversed this silencing, restoring eGFP expression.
• Mechanism: This rescue required:
  1. DNA Binding: The DNA-binding mutant (RRLL) failed to rescue.
  2. Prion-like Domain: The mutant lacking the prion-like domain (YS37) failed to rescue, indicating condensate formation is necessary.
  3. Non-Homologous Recruitment: This occurred despite the absence of human CBP/p300 or BAF, suggesting EWS::FLI1 recruited the yeast SAGA complex (specifically the HAT Gcn5) to acetylate histones and open the chromatin.

4. Key Contributions

1. Identification of a Minimal Functional System: Demonstrated that S. cerevisiae is a viable model to dissect the core, evolutionarily conserved functions of EWS::FLI1, separating them from metazoan-specific cofactor dependencies.
2. Discovery of SAGA as a Key Interactor: Revealed that in the absence of human p300/CBP and BAF, EWS::FLI1 recruits the yeast SAGA complex to drive chromatin remodeling.
3. Proof of Pioneer Factor Activity: Provided direct evidence that EWS::FLI1 acts as a pioneer factor capable of binding to and converting silent GGAA-microsatellites into active enhancers even in a non-mammalian system lacking native GGAAμSats and specific cofactors.
4. Dissociation of Binding and Reprogramming: Showed that while EWS::FLI1 can bind DNA and recruit Pol II in yeast, the extensive transcriptome reprogramming characteristic of Ewing sarcoma is strictly dependent on animal-specific pathways.

5. Significance

• Evolutionary Insight: The study suggests that the ability of EWS::FLI1 to bind GGAA repeats and initiate chromatin opening is an ancient, conserved property of the fusion protein. The "neomorphic" transformation of the cell, however, is a result of the fusion protein hijacking a complex, metazoan-specific network of cofactors (ETS factors, BAF, etc.).
• Therapeutic Implications: Understanding that the core "pioneer" function relies on recruiting HAT complexes (like SAGA/p300) highlights these chromatin modifiers as potential therapeutic targets. If EWS::FLI1 can utilize alternative HATs (like SAGA) in the absence of p300, targeting the specific interaction interface or the condensate formation (prion-like domain) may be more effective than targeting a single co-activator.
• Model Utility: Validates the use of simple eukaryotic models to deconstruct complex oncogenic mechanisms, isolating the "core engine" of the fusion protein from the "chassis" of the host cell.

In summary, the paper concludes that EWS::FLI1's core ability to drive GGAAμSat-dependent gene expression is a conserved, ancient property, while the extensive transcriptome reprogramming seen in cancer is dependent on co-factors specific to animal cells.